Anti-coagulants therapy
| Description | Cumarin therapy: INR (Quick’s test) Therapy with non-fractioned, high-molecular heparin (HMWM): PTT test, thrombocyte count (for evaluation of HIT-II). In case of insufficient extension of the PTT, evaluation of the anti-factor Xa-activity may be carried out. Pyridinoline in the urine (on suspicion of osteoporosis). Therapy with low-molecular heparin (LMW) (Clexane®, Fraxiparin® and others): Anti-factor Xa-activity. Anti-factor Xa-check-ups are not generally required (exceptions: pregnancy, kidney insufficiency), thrombocyte count, for detection of HIT-II, this however is less common than after HMV-heparin. |
More Results for the letter A
- Alveolitis, exogenous allergic
- Alzheimer’s dementia
- Amalgam
- Amebiasis
- Amenorrhea
- Amyloidosis:
- Amyotrophic lateral sclerosis (ALS)
- Anabolic intake
- Analgesic-related nephropathy
- Anaphylactic shock
- Ancylosing spondylitis (Bechterew’s disease)
- Androgen-deficiency in men
- Androgenisation phenomena
- Anemia-diagnostics
- Angina pectoris
- Angio-neurotic edema
- Ankylosing spondylitis
- Anorexia nervosa
- Anovulation
- Anti-coagulants therapy
- Anti-convulsants (Initial drug regimen / therapy monitoring)
- Anti-epileptics
- Anti-NMDA-receptor-encephalitis
- Anti-phospholipid syndrome
- Anti-synthetase syndrome
- Antibody insufficiency
- Antioxidants
- Anuria
- Aphthen
- Aplastic anemia